NRG-GY018

A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475) in addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer

For more information about this clinical trial, click here

Schema & Eligibility NRG-GY018

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Mercy Hospital, St. Louis, MO

Ask your physician about participating in this clinical trial or call us.